insitro

@insitro

Causal AI for Human Health ╰┈➤ Find us on Substack: DeepPhenotype.substack.com

South San Francisco, CA

insitro.com

Replies Reposts Media

insitro
@insitro
Aug 26
The second issue of Deep Phenotype, insitro’s Substack publication on scaled biology and deep causality, is now live. In “Mapping Causal Human Biology: From Outcome to Mechanism,” insitro CEO and founder @DaphneKoller examines the problem at the center of drug discovery – moving
insitro
@insitro
Aug 12
insitro founder and CEO @DaphneKoller recently stopped by The Information Bottleneck podcast to chat with hosts @ziv_ravid and @Hellisotherpe10 about causal biology and why AI in drug discovery is a fundamentally different problem than AI in language or vision. The conversation
1
insitro
@insitro
Aug 4
Exciting day at insitro with the launch of Deep Phenotype, our new Substack publication covering scaled biology and deep causality. Over the coming months, we'll separate truth from hype as we explore causal human biology, physical AI, and the work of turning discovery into
00:00
1
insitro
@insitro
Jul 25
If you feed an LLM just a few of @insitro founder and CEO @DaphneKoller’s accomplishments at the frontiers of artificial intelligence and machine learning, it will tell you what we already know: "The through line is the belief that if we can represent uncertainty correctly,
00:00
insitro
@insitro
Jun 19
We’re heading to the 2026 BIO International Convention in San Diego next week, where insitro CFO/CBO Mary Rozenman, PhD, will participate in the panel discussion, “Beyond the Hype: How AI is Actually Transforming Biopharma in 2026.” Expect a dynamic conversation as Mary joins
2